C4 Therapeutics, Inc. Common Stock CCCC
i
Market dataready · fetched 2026-11-11T14:01:32.744Z
Delta surfaceAlpaca · derived absolute-delta buckets · 2026-11-20
Calculation methodologyOptions historyIV: ThetaData historical Greeks, equal-weight mean of call/put 50-delta IV across the next four listed Friday-cycle expirations, including holiday shifts verified against ThetaData’s market calendar. Missing inputs leave gaps. Skew: equal-weight mean of put minus call IV across those four expirations. IV-implied move history: mean of each expiration’s average call/put IV multiplied by the square root of remaining calendar days divided by 365.25; percentage of spot, not a quoted straddle premium.
History dataPriceAlpaca · sip · 2026-11-11T11:11:36.060221765Z
FundamentalsSEC EDGAR · ready · as of 2026-09-30 · fetched 2026-11-11T14:01:32.380971+00:00
C4 Therapeutics, Inc. Common Stock options
Table
| Delta | Calls | Puts | ||||
|---|---|---|---|---|---|---|
| Pseudo strike | IV | B/E move | Pseudo strike | IV | B/E move | |
| 20Δ | 2.23 | 231.6% | 29.8% | |||
| 25Δ | 2.37 | 202.9% | 25.1% | |||
| 30Δ | 2.52 | 174.1% | 20.4% | |||
| 35Δ | 2.67 | 145.4% | 15.7% | |||
| 40Δ | 3.35 | 103.0% | 15.2% | 2.82 | 116.7% | 11.0% |
| 45Δ | 3.23 | 93.3% | 11.4% | 2.97 | 87.9% | 6.3% |
| 50Δ | 3.10 | 83.7% | 7.6% | 3.24 | 93.6% | 4.9% |
| 55Δ | 2.97 | 78.5% | 4.5% | 3.54 | 108.2% | 4.4% |
| 60Δ | 2.85 | 88.0% | 4.0% | 3.84 | 122.9% | 3.9% |
| 65Δ | 2.74 | 97.4% | 3.6% | 4.15 | 137.5% | 3.4% |
| 70Δ | 2.62 | 106.9% | 3.1% | 4.45 | 152.1% | 2.9% |
| 75Δ | 2.50 | 116.3% | 2.6% | 4.75 | 166.8% | 2.4% |
| 80Δ | 2.38 | 125.7% | 2.1% | 5.05 | 181.4% | 1.9% |
20Δ
- Pseudo strike
- IV
- B/E move
- Pseudo strike
- 2.23
- IV
- 231.6%
- B/E move
- 29.8%
25Δ
- Pseudo strike
- IV
- B/E move
- Pseudo strike
- 2.37
- IV
- 202.9%
- B/E move
- 25.1%
30Δ
- Pseudo strike
- IV
- B/E move
- Pseudo strike
- 2.52
- IV
- 174.1%
- B/E move
- 20.4%
35Δ
- Pseudo strike
- IV
- B/E move
- Pseudo strike
- 2.67
- IV
- 145.4%
- B/E move
- 15.7%
40Δ
- Pseudo strike
- 3.35
- IV
- 103.0%
- B/E move
- 15.2%
- Pseudo strike
- 2.82
- IV
- 116.7%
- B/E move
- 11.0%
45Δ
- Pseudo strike
- 3.23
- IV
- 93.3%
- B/E move
- 11.4%
- Pseudo strike
- 2.97
- IV
- 87.9%
- B/E move
- 6.3%
50Δ
- Pseudo strike
- 3.10
- IV
- 83.7%
- B/E move
- 7.6%
- Pseudo strike
- 3.24
- IV
- 93.6%
- B/E move
- 4.9%
55Δ
- Pseudo strike
- 2.97
- IV
- 78.5%
- B/E move
- 4.5%
- Pseudo strike
- 3.54
- IV
- 108.2%
- B/E move
- 4.4%
60Δ
- Pseudo strike
- 2.85
- IV
- 88.0%
- B/E move
- 4.0%
- Pseudo strike
- 3.84
- IV
- 122.9%
- B/E move
- 3.9%
65Δ
- Pseudo strike
- 2.74
- IV
- 97.4%
- B/E move
- 3.6%
- Pseudo strike
- 4.15
- IV
- 137.5%
- B/E move
- 3.4%
70Δ
- Pseudo strike
- 2.62
- IV
- 106.9%
- B/E move
- 3.1%
- Pseudo strike
- 4.45
- IV
- 152.1%
- B/E move
- 2.9%
75Δ
- Pseudo strike
- 2.50
- IV
- 116.3%
- B/E move
- 2.6%
- Pseudo strike
- 4.75
- IV
- 166.8%
- B/E move
- 2.4%
80Δ
- Pseudo strike
- 2.38
- IV
- 125.7%
- B/E move
- 2.1%
- Pseudo strike
- 5.05
- IV
- 181.4%
- B/E move
- 1.9%
Options history
Table
| Date | IV (%) |
|---|---|
| 126.62% | |
| 112.11% | |
| 137.93% | |
| 123.75% | |
| 125.94% | |
| 117.17% | |
| 124.95% | |
| 113.22% | |
| 117.68% | |
| 108.81% |
Biotechnology
CDXS
Codexis, Inc. discovers, develops and sells biocatalysts. The company is headquartered in Redwood City, California.
More →CELC
Description unavailable
More →CELU
Celularity Inc. is a pioneering biotechnology company focused on regenerative medicine through its innovative cellular products derived from the placenta. The company is advancing…
More →CGEM
Description unavailable
More →CGON
Description unavailable
More →CHRS
Description unavailable
More →